Asthma in Medical Technology

Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma

... combination for the maintenance treatment of asthma in patients 12 years of age and older. ... the largest segment of the worldwide market for asthma and chronic obstructive pulmonary disease (COPD) ... and formoterol fumarate for the treatment of asthma in patients younger than 12 years of age and for ...

CareFirst BCBS Covers eNO Measurement for Diagnosis, Asthma Treatment

... medically necessary in the management of asthma patients. CareFirst is the largest health care ... have reported that eNO is predictive of asthma in patients with normal lung function, predictive ... valuable impact that eNO measurement can have on asthma treatment. We are working to encourage similar ...

ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients

... powder inhaler) for the treatment of bronchial asthma in adults.(1) "We are pleased to announce ... inhaled corticosteroid to treat bronchial asthma in an innovative dry powder inhaler device," ... is approved for the maintenance treatment of asthma in patients 4 years of age and older. ASMANEX ...

PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS

... atopic asthma. Results showed decreases in mean asthma symptom scores without a change in lung function ... eFlow Nebulizer System has similar effects on asthma control, symptoms, lung function, and FeNO levels ... children (11.9 +/- 2.8 years) with stable atopic asthma were randomized to inhale either IsoCrom, ...

Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma

... Non-drug Procedure for asthma Highlighted at ATS 2009 SUNNYVALE, Calif., May 18 /PRNewswire/ -- Results of the asthma Intervention Research 2 (AIR2) Trial of the ... in quality of life measurements, reductions in asthma attacks (severe exacerbations) and emergency room ...

American Lung Association Study to be Published in the 'New England Journal of Medicine' Finds Prescription Heartburn Medication Does Not Control Asthma Symptoms as Previously Thought

... Stop Prescribing Potent Heartburn Medications to asthma Patients Without Frequent Symptoms of Gastric ... For nearly 20 years, it was believed that severe asthma symptoms such as coughing, wheezing and ... conducted by the American Lung Association's asthma Clinical Research Centers (ACRC) finds the ...

New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits

... to examine factors impacting patient response to asthma medications FRANKLIN LAKES, N.J., March 14 ... room (ER) visits and hospitalizations for asthma patients taking cholesterol-lowering statins in addition to common asthma treatments. The study was jointly conducted by ...

Pharmaxis Announces New Drug Application Submission for Aridol(TM)

... with the FDA over the coming months." asthma affects more than 34 million people in the ... management strategies that help to control asthma and prevent worsening of its symptoms. ... has been included in the Global Initiative for asthma guidelines, and in the ....

Research Finding Could Revolutionize Asthma Treatment

... FRANCISCO, Feb. 26 /PRNewswire/ -- The American asthma Foundation announced a research breakthrough ... high blood pressure may also bring relief to many asthma sufferers. (Photo: ... Dean Smith, Executive Director of the American asthma Foundation (AAF), said, "Drugs known as beta ...

MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints

... did not meet its co-primary endpoints, asthma control as assessed by changes from baseline in ... and study groups experienced improvements in asthma symptoms, but the differences were not ... The co-primary endpoints evaluated asthma control as assessed by changes from baseline as ...

AstraZeneca's Partner, MAP Pharmaceuticals, Announces Phase 3 Study of Unit Dose Budesonide in Children with Asthma Did Not Meet Primary Endpoints

... for the potential treatment of children with asthma did not meet its co-primary endpoints: asthma control as assessed by changes from baseline in ... with AstraZeneca for the potential treatment of asthma in children, and MAP0004 is being developed for ...

Inverseon's Founder and SAB Member Published in PNAS

... signaling is required for the development of an asthma phenotype in a murine model." The article was ... supportive commentary on this essential asthma signaling pathway by Raymond Penn of the ... in Beta2-adrenoceptor signaling attenuates the asthma phenotype. The current work extends the prior ...

Global Health Research Foundation Awarded $25,000 Grant From Westly Foundation to Study Asthma in California's Central Valley

... $25,000 grant from the Westly Foundation to fund asthma treatment in California's Central Valley, a region with the highest level of asthma cases in the state. The grant will help fund data ... better focus scarce resources on the most severe asthma cases. The data will also be used in a study of ...

K-State Researcher Finds Correlation Between Childhood Obesity and Asthma

... been seeing over the past several decades in asthma prevalence as well as obesity prevalence," ... it is possible that they had the early stages of asthma and they didn't know it. "They might not ... ever trigger it," she said. When an asthma diagnosis is made, Rosenkranz said it is ...

AstraZeneca Responds to FDA Joint Advisory Committees' Recommendation on SYMBICORT(R)

... - completed a review of the benefits and risks of asthma medications containing long-acting beta-agonists ... outweigh the risks in adult and adolescent asthma patients. Howard Hutchinson, M.D., Chief ... for the long-term maintenance treatment of asthma and is available in two different inhalers, ...

Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids

... 78% of childhood asthma - Allergic asthma affects 2.5 million children in the US under the ... today at the American College of Allergy, asthma & Immunology (ACAAI) show that Xolair(R) ... 11 with moderate or severe persistent allergic asthma inadequately controlled with inhaled ...

Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD

... consistent with the established profiles in asthma for each product.(2,4) In addition, an analysis ... for the long-term maintenance treatment of asthma in patients 12 years of age and older.(6) ... for the long-term maintenance treatment of asthma in patients 12 years of age and ...

Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients

... with no evidence of local irritancy following asthma patients' inhalation of a single 10 mg dose. ... potential for treating uncontrolled asthma when delivered as an inhalation powder," said ... a method of administration that doctors and asthma patients have embraced." Ten subjects with ...

More Findings on Gene Involved in Childhood Asthma

... PHILADELPHIA, Sept. 15 /PRNewswire-USNewswire/ -- asthma researchers have found that a gene variant known ... on chromosome 17, as contributing to childhood asthma among British and German children. The current ... and showed that the gene plays a role in asthma of any severity level," said study leader and ...

Newly Released Data on Onset of Effect and Patient Perception With SYMBICORT in Adults With Asthma

... patients receiving the maintenance combination asthma therapy SYMBICORT(R) (budesonide/formoterol ... were published today in the Annals of Allergy, asthma and Immunology, also showed patients were more ... double-blind, placebo-controlled studies in asthma patients who were previously treated with ...

MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting

... 2 study is also important because migraine and asthma are frequently co-morbid conditions." MAP0004 ... for the potential treatment of pediatric asthma and migraine respectively. MAP Pharmaceuticals' ... early clinical development for the treatment of asthma and chronic obstructive pulmonary disease. ...

Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma

... 10 /PRNewswire/ -- African American patients with asthma treated with Advair Diskus, a combination of ... alone to control their asthma. "Uncontrolled asthma is a critical public health issue for ... treatment with Advair helps improve day-to-day asthma control," said William Bailey, M.D., lead author ...

AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six

... for the long-term maintenance treatment of asthma in pediatric patients ages 6 to 11 years old. ... the long-term maintenance treatment of asthma in patients 12 years and older. "Millions of ... treatment option for the long-term maintenance of asthma in young children whose condition is not ...

Study Analyzed SYMBICORT(R) in Children with Persistent Asthma

... efficacy measures of the maintenance combination asthma therapy, SYMBICORT(R) (budesonide/formoterol ... by ICS therapy, may have their sleep affected by asthma symptoms,"(6) said Kathy Lampl, MD, Director, ... children who have moderate to severe persistent asthma or are not controlled with ICS therapy alone, ...

Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM)

... Additional Improvement in Overall asthma Control RESEARCH TRIANGLE PARK, N.C. and ... 18 /PRNewswire-FirstCall/ -- Patients with both asthma and allergic rhinitis, or seasonal ... to patients treated with Advair alone in their asthma symptoms or albuterol use. In another comparison ...

Apieron, Inc. Begins Customer Shipments of the Insight(TM) eNO System

... Measures Exhaled Nitric Oxide for More Targeted asthma Control MENLO PARK, Calif., May 1 /PRNewswire/ ... clinical indicator of airway inflammation and asthma control. With the use of eNO measurements, ... adjust inhaled corticosteroid therapy to optimize asthma control and avoid exacerbations or 'asthma ...

AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication

... for the long-term maintenance treatment of asthma in patients 12 years and older. "COPD is a ... for the long-term maintenance treatment of asthma in patients 12 years of age and ... . (8) asthma and Allergy Foundation of ....

MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13

... the antibody's potential to help patients with asthma gain control of their often debilitating ... depth of data we are gathering for this potential asthma treatment." The Phase 2 clinical trial is ... designated as drug candidates. About Asthma asthma is a chronic disease of the airways that may ...

MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics

... lock out after a maximum number of doses. About asthma and COPD asthma is a chronic respiratory disorder that is ... chest tightness, breathlessness and coughing. asthma is a variable condition that can change both ...

MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate

... for the safety of our next generation pediatric asthma therapy." The company plans to present the ... nebulized budesonide for treating pediatric asthma in children from 12 months to eight years of age. ... is the only corticosteroid approved for treating asthma in pregnant women and in children as young as 12 ...

New Survey Suggests Cultural Ambivalence to Allergies Leaves Many Suffering Needlessly

... said Mike Tringale, director of external affairs, asthma and Allergy Foundation of America (AAFA). ... director of external affairs, Allergy & asthma Foundation of America. About the Attitudes ... . References: 1 American Academy of Allergy asthma & Immunology Topic of the Month: March 2007: ...

Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma

... - Study to Assess MEDI-528 in Stable asthma and Exercise-Induced ... the potential of MEDI-528 in patients with stable asthma and exercise-induced bronchoconstriction. Genaera ... is currently evaluating MEDI-528 in patients with asthma in a series of phase 2 clinical trials. The goal ...

MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma

... Initiates Phase 2a Trial in Patients with Stable asthma and Exercise-Induced ... antibody (MAb), MEDI-528, in patients with stable asthma and exercise-induced bronchoconstriction. This ... doses of MEDI-528 in adult patients with stable asthma and exercise-induced bronchoconstriction. ...

Study Compares Bronchodilatory Effects of SYMBICORT(R) and Advair in Adults With Asthma

... a new study demonstrated that the combination asthma maintenance therapy, SYMBICORT(R) ... presented at the American Academy of Allergy, asthma & Immunology Annual Meeting held in Philadelphia, ... 2008. "SYMBICORT is a combination of two proven asthma medications - budesonide and formoterol. It ...

GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program

... ) today announced the start of large Phase 2b asthma dose-optimization studies with both the lead ... GSK began enrolling patients with mild to severe asthma in the '698 Phase 2b clinical program on 21st ... 2007 and began enrolling patients with persistent asthma in the '444 Phase 2b clinical program on 29th ...

Childhood Influenza Immunization Coalition Encourages Vaccination Throughout the Influenza Season

... and high risk individuals, such as those with asthma and diabetes, since the influenza virus spreads ... vaccines. Coalition members include Allergy & asthma Network Mothers of Asthmatics, American Academy ... State and Territorial Health Officials, asthma and Allergy Foundation of America, Canyon Ranch ...

The New England Journal of Medicine Publishes First Clinical Results for MedImmune's Chitinase-like Protein YKL-40 in Patients With Asthma

... to those without disease, and correlate with asthma severity. Supplementing preclinical evidence ... significantly elevated in patients with severe asthma and that this molecule may be a biomarker for asthma severity, compared to patients with milder ...

Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease

... a higher than expected number of COPD and severe asthma patients had abnormal low levels of alpha-1 ... all patients with moderate or severe persistent asthma and/or COPD with chronic pulmonary symptoms ... following simple screening criteria: persistent asthma and/or COPD patients with loss of lung function ...

MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma

... of this potential treatment for patients with asthma and to further explore the role of IL-9 in the ... moderate-to-severe, persistent asthma. About asthma asthma is a chronic disease of the airways that may ...

Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program

... fluid of adult patients with atopic asthma are underway. About IL-9 As mentioned above, ... moderate-to-severe, persistent asthma. About asthma asthma is a chronic disease of the airways that may ...